Radiochemist
Emily Tow Jackson Chair in Oncology; Vice Chair for Research, Department of Radiology; Chief, Radiochemistry and Imaging Sciences Service
About Me
I am Vice Chair for Research, Chief of the Radiochemistry and Imaging Sciences Service, and Director of the Radiochemistry and Molecular Imaging Probe Core Facility. I head a laboratory in the Sloan Kettering Institute’s molecular pharmacology program and am a professor at the Gerstner Sloan Kettering Graduate School of Biomedical Sciences. I have published more than 200 papers, books, book chapters, and reviews on cancer imaging. I serve on grant review panels for the National Institutes of Health and National Cancer Institute and a number editorial boards.
I am researching new ways to use PET imaging to diagnose cancer as well as developing new radioimmunotherapies for treating this disease. My research is supported by the National Institutes of Health, the Department of Education, and philanthropy.
See My Colleagues
Insurance
Most major health insurers offer plans that include MSK as one of their in-network providers. If MSK is in-network, it means all our doctors are too. Medicaid and New York State Medicare also provide benefits for care at MSK.
Learn moreClinical Trials
As home to one of the world’s top cancer research centers, Memorial Sloan Kettering is typically involved in more than 900 clinical trials at a given time. Currently, clinical trials focused on the conditions I treat are enrolling new patients. If you’re interested in joining a clinical trial, click to learn about the trial’s purpose, eligibility criteria, and how to get more information.
Learn more
